Vyne Therapeutics Inc. (VYNE)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
18. 31
-0.59
-3.1217%
$
19.07M Market Cap
- P/E Ratio
- Div Yield
60,721 Volume
-1 Eps
$ 18.9
Previous Close Want to track VYNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vyne Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 365.96 | $11,910.17 | $6,916.64 | -$4,993.53 | -41.93% |
 Jeffrey Gundlach DoubleLine Capital LP | 448 | $2.57M | $8,467.2 | -$2.56M | -99.67% |
| KJ Ken Joseph Braidwel LLP | 18,321.54 | $547,356.01 | $346,277.11 | -$201,078.9 | -36.74% |
 George Song Superstring Capital Management LP | 1,225.38 | $39,867.74 | $23,159.68 | -$16,708.06 | -41.91% |
 Paul V. Ryan Jr FLAGSHIP WEALTH ADVISORS, LLC | 0.02 | $0.63 | $0.38 | -$0.25 | -39.68% |
| AH Anders Hove Acorn Capital Advisors LLC | 28.5 | $2,251.5 | $538.65 | -$1,712.85 | -76.08% |
| LC Leslie Childs MB Levis & Associates LLC | 20.82 | $3,206.01 | $393.5 | -$2,812.51 | -87.73% |
2026 © Marketlog. All Rights Reserved.
